scholarly journals Marine Polysaccharides as a Versatile Biomass for the Construction of Nano Drug Delivery Systems

Marine Drugs ◽  
2021 ◽  
Vol 19 (6) ◽  
pp. 345
Author(s):  
Ying Sun ◽  
Xiaoli Ma ◽  
Hao Hu

Marine biomass is a treasure trove of materials. Marine polysaccharides have the characteristics of biocompatibility, biodegradability, non-toxicity, low cost, and abundance. An enormous variety of polysaccharides can be extracted from marine organisms such as algae, crustaceans, and microorganisms. The most studied marine polysaccharides include chitin, chitosan, alginates, hyaluronic acid, fucoidan, carrageenan, agarose, and Ulva. Marine polysaccharides have a wide range of applications in the field of biomedical materials, such as drug delivery, tissue engineering, wound dressings, and sensors. The drug delivery system (DDS) can comprehensively control the distribution of drugs in the organism in space, time, and dosage, thereby increasing the utilization efficiency of drugs, reducing costs, and reducing toxic side effects. The nano-drug delivery system (NDDS), due to its small size, can function at the subcellular level in vivo. The marine polysaccharide-based DDS combines the advantages of polysaccharide materials and nanotechnology, and is suitable as a carrier for different pharmaceutical preparations. This review summarizes the advantages and drawbacks of using marine polysaccharides to construct the NDDS and describes the preparation methods and modification strategies of marine polysaccharide-based nanocarriers.

2018 ◽  
Vol 6 (7) ◽  
pp. 1011-1017 ◽  
Author(s):  
Tiantian Wu ◽  
Hai Huang ◽  
Yaping Sheng ◽  
Hongdong Shi ◽  
Yuanzeng Min ◽  
...  

The PEGylation of anti-EGFR nanobodies was achieved via a transglutaminase catalyzed reaction through a Q-tag. The nanobody tethered drug delivery system exhibits superior specificity to EGFR positive tumor cells.


1997 ◽  
Vol 76 (8) ◽  
pp. 567-570 ◽  
Author(s):  
Rolf Lehner ◽  
Heribert Brugger ◽  
Marcus M. Maassen ◽  
Hans-Peter Zenner

Local therapy of middle and inner ear diseases is being used, but is restricted to cases of ear drum perforation or to repeated invasive intratympanic drug application by the physician. In accordance with the Medical Device Directive (class III), a bone-anchored, totally implantable drug delivery system (TI-DDS) has been developed. It includes a micropump for subcutaneous, patient-controlled activation, a drug reservoir and a septum port. A thin guide-wired catheter leads from the pump outlet to the point of application in the mastoid or middle ear cavities. Local inner ear therapy with suitable drugs is possible by positioning the catheter's end near the round window membrane. The system requires no battery and will offer a wide range of patient-controlled bolus applications (25 μl per activation). We first analyzed the three-dimensional implantation geometry of the mastoid cavity. Basic micromechanical problems have been solved in order to create several prototypes. The TI-DDS has already undergone extensive in vitro testing. Recent results of pump rate precision and digital pressure force testing are promising. Local drug treatment for conditions such as lidocaine-sensitive tinnitus, secretory otitis media, Meniere's disease, localized pain and intralesional cancer is under discussion. Furthermore, local application of future biotechnological trophic factors for inner ear treatment is anticipated. The basic engineering is completed and initial animal tests are in preparation.


2020 ◽  
Vol 10 (9) ◽  
pp. 3431-3442
Author(s):  
Qiangqiang Zhao ◽  
Bin Wu ◽  
Yinghui Shang ◽  
Xueyuan Huang ◽  
Hang Dong ◽  
...  

2021 ◽  
Vol 536 ◽  
pp. 147741 ◽  
Author(s):  
Palanivel Sathishkumar ◽  
Zhaofa Li ◽  
Raji Govindan ◽  
Rajarajeswaran Jayakumar ◽  
Chaoyang Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document